OBJECTIVES: Persons with fibromyalgia (FM) report having cognitive dysfunction. Neuropsychological performance was compared across a variety of domains in 43 women with FM (Mage = 63 years) and in 44 women without FM (Mage = 65 years). METHOD: Measures included explicit memory (Consortium to Establish a Registry for Alzheimer's Disease [CERAD] immediate/delayed recall, delayed recognition), aspects of executive function including interference/inhibition (Stroop Color/Word test), working memory (Digit Span Forward/Backward), set-shifting/complex sequencing (Trails B), monitoring (verbal fluency: naming animals), processing speed (Trails A, Digit Symbol Substitution Coding), and problem solving (Everyday Problems Test). RESULTS: Women with FM performed more poorly than controls on executive function (Stroop Color/Word) and one processing speed measure (Digit Symbol Substitution Coding). DISCUSSION: Results partly support altered cognitive function in FM. Mixed findings across cognitive domains among individuals with or without FM is consistent with the literature and suggest that factors beyond those typically controlled for (e.g., heterogeneity in FM) may be influencing findings. Future research is warranted.
OBJECTIVES:Persons with fibromyalgia (FM) report having cognitive dysfunction. Neuropsychological performance was compared across a variety of domains in 43 women with FM (Mage = 63 years) and in 44 women without FM (Mage = 65 years). METHOD: Measures included explicit memory (Consortium to Establish a Registry for Alzheimer's Disease [CERAD] immediate/delayed recall, delayed recognition), aspects of executive function including interference/inhibition (Stroop Color/Word test), working memory (Digit Span Forward/Backward), set-shifting/complex sequencing (Trails B), monitoring (verbal fluency: naming animals), processing speed (Trails A, Digit Symbol Substitution Coding), and problem solving (Everyday Problems Test). RESULTS:Women with FM performed more poorly than controls on executive function (Stroop Color/Word) and one processing speed measure (Digit Symbol Substitution Coding). DISCUSSION: Results partly support altered cognitive function in FM. Mixed findings across cognitive domains among individuals with or without FM is consistent with the literature and suggest that factors beyond those typically controlled for (e.g., heterogeneity in FM) may be influencing findings. Future research is warranted.
Authors: Barbara J Cherry; Jie Weiss; Brandon K Barakat; Dana N Rutledge; C Jessie Jones Journal: Arch Phys Med Rehabil Date: 2009-12 Impact factor: 3.966
Authors: Tari D Topolski; James LoGerfo; Donald L Patrick; Barbara Williams; Julie Walwick; Marsha B Patrick Journal: Prev Chronic Dis Date: 2006-09-15 Impact factor: 2.830
Authors: Diana M Higgins; Aaron M Martin; Dewleen G Baker; Jennifer J Vasterling; Victoria Risbrough Journal: Clin J Pain Date: 2018-03 Impact factor: 3.442
Authors: Anna L Kratz; Daniel Whibley; Samsuk Kim; Martin Sliwinski; Daniel Clauw; David A Williams Journal: Arthritis Care Res (Hoboken) Date: 2020-11-09 Impact factor: 4.794
Authors: Sofia Martinsen; Pär Flodin; Jonathan Berrebi; Monika Löfgren; Indre Bileviciute-Ljungar; Martin Ingvar; Peter Fransson; Eva Kosek Journal: PLoS One Date: 2014-10-02 Impact factor: 3.240